Literature DB >> 6333462

Avian lymphokines: an improved method for chicken IL-2 production and assay. A Con A-erythrocyte complex induces higher T cell proliferation and IL-2 production than does free mitogen.

G Krömer, K Schauenstein, G Wick.   

Abstract

Optimized production conditions and a functional assay of avian T cell growth factor (TCGF) or interleukin 2 (IL-2) are described. Treatment of lymphocytes with mitogen (Con A)-coated chicken red blood cells (MRC) resulted in markedly enhanced mitogenic response and IL-2 secretion compared to stimulation with free Con A. A positive correlation (r = 0.89) was found between mitogenic response and IL-2 activity of conditioned media. Enrichment of target cells, i.e., Con A lymphoblasts, by Percoll consistently improved the sensitivity of the IL-2 assay. The half-life time of chicken IL-2 at 40 degrees C was 9.7 +/- 1.7 h, which was considerably shorter than the value obtained for murine IL-2, i.e., 53.1 +/- 8.5 h. High concentrations of conditioned media were found to contain a dialysable factor that suppressed IL-2 promoted blast proliferation. The relevance of the data for in vitro analysis of T cell function as well as for establishing T cell lines in the chicken system are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6333462     DOI: 10.1016/0022-1759(84)90402-2

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  2 in total

1.  In-vivo treatment with 5-azacytidine causes degeneration of central lymphatic organs and induces autoimmune disease in the chicken.

Authors:  K Schauenstein; A Csordas; G Krömer; H Dietrich; G Wick
Journal:  Int J Exp Pathol       Date:  1991-06       Impact factor: 1.925

2.  Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein 65.

Authors:  Q Xu; R Kleindienst; W Waitz; H Dietrich; G Wick
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.